{"schemaVersion":"peptidescanner-peptide-evidence-feed/v1","canonicalUrl":"https://peptidescanner.com/feeds/peptides/melanotan-ii.json","peptide":{"slug":"melanotan-ii","name":"Melanotan II","url":"https://peptidescanner.com/peptides/melanotan-ii/"},"release":{"label":"Beta · 17 Nov 2026","reviewedAt":"2026-11-17"},"entryCount":17,"entries":[{"objectId":"story:federal-register-2016-27244:v1","state":"current","stateChangedAt":"2026-11-15","title":"Federal Register notice 2016-27244","domain":"Regulatory","dateInSource":"2016-11-14","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/federal-register-2016-27244/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#federal-register-2016-27244-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.md#federal-register-2016-27244-v1","contentSha256":"dbfc6bc8ea91ed60bbbf2ea219f2be338a0202804477fb242127a854f3c9c215"},{"objectId":"story:pubmed-pmid-11035391-melanotan-ii:v1","state":"current","stateChangedAt":"2026-11-15","title":"Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II.","domain":"Literature metadata","dateInSource":"2019-11-04","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-11035391-melanotan-ii/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-11035391-melanotan-ii-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.md#pubmed-pmid-11035391-melanotan-ii-v1","contentSha256":"a84fd67662d0397aa2402afab62914621d3e15f4c79bbc1c82e0770f671aa50b"},{"objectId":"story:pubmed-pmid-1336500-melanotan-ii:v1","state":"current","stateChangedAt":"2026-11-15","title":"High-performance liquid chromatographic assay for the alpha-melanotropin[4,10] fragment analogue (Melanotan-II) in rat plasma.","domain":"Literature metadata","dateInSource":"2019-06-29","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-1336500-melanotan-ii/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-1336500-melanotan-ii-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.md#pubmed-pmid-1336500-melanotan-ii-v1","contentSha256":"727c38f94eb23f9211ec1b88fe7f70ef0ff6b691fd989ee70114a27ffe40de59"},{"objectId":"story:pubmed-pmid-19043625-melanotan-ii:v1","state":"current","stateChangedAt":"2026-11-15","title":"The first preparative solution phase synthesis of melanotan II.","domain":"Literature metadata","dateInSource":"2021-10-20","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-19043625-melanotan-ii/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-19043625-melanotan-ii-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.md#pubmed-pmid-19043625-melanotan-ii-v1","contentSha256":"ac2e3663974649bbb2c66539105aa03aee187f38b1dd66a0937719fa16cea3de"},{"objectId":"story:pubmed-pmid-20965250-melanotan-ii:v1","state":"current","stateChangedAt":"2026-11-15","title":"Nanostructured porous silicon microparticles enable sustained peptide (Melanotan II) delivery.","domain":"Literature metadata","dateInSource":"2016-11-25","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-20965250-melanotan-ii/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-20965250-melanotan-ii-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.md#pubmed-pmid-20965250-melanotan-ii-v1","contentSha256":"b9a403c55e996a920bff789b1fb739ca80140209bf7bf756124de8d9eca69304"},{"objectId":"story:pubmed-pmid-24771717-melanotan-ii:v1","state":"current","stateChangedAt":"2026-11-15","title":"Identification and characterization by LC-UV-MS/MS of melanotan II skin-tanning products sold illegally on the Internet.","domain":"Literature metadata","dateInSource":"2019-12-10","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-24771717-melanotan-ii/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-24771717-melanotan-ii-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.md#pubmed-pmid-24771717-melanotan-ii-v1","contentSha256":"5979c1508d0682b93c762cddfc1567d86b91597833fa68b596b99ecef254b33d"},{"objectId":"story:pubmed-pmid-26108334-melanotan-ii:v1","state":"current","stateChangedAt":"2026-11-15","title":"Evidence that Melanocortin Receptor Agonist Melanotan-II Synergistically Augments the Ability of Naltrexone to Blunt Binge-Like Ethanol Intake in Male C57BL/6J Mice.","domain":"Literature metadata","dateInSource":"2019-09-29","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-26108334-melanotan-ii/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-26108334-melanotan-ii-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.md#pubmed-pmid-26108334-melanotan-ii-v1","contentSha256":"27b1937040c576226d3e9c043411344fac04d8d1809f225d60460b5421daa925"},{"objectId":"story:pubmed-pmid-28905366-melanotan-ii:v1","state":"current","stateChangedAt":"2026-11-15","title":"The unregulated use of melanotan-II is of public health interest to Australian dermatologists.","domain":"Literature metadata","dateInSource":"2019-03-14","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-28905366-melanotan-ii/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-28905366-melanotan-ii-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.md#pubmed-pmid-28905366-melanotan-ii-v1","contentSha256":"ea8560c4099c3545fb550f8578daaac8c92f6460fd79160b9158306e1e710c48"},{"objectId":"story:pubmed-pmid-31953620-melanotan-ii:v1","state":"current","stateChangedAt":"2026-11-15","title":"Melanotan II: a possible cause of renal infarction: review of the literature and case report.","domain":"Literature metadata","dateInSource":"2021-06-21","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-31953620-melanotan-ii/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-31953620-melanotan-ii-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.md#pubmed-pmid-31953620-melanotan-ii-v1","contentSha256":"3c79936e8755c0d6a88b50d0660dc75227283eb3fd65ca8ef5baa8998d1a39d4"},{"objectId":"story:pubmed-pmid-32674774-melanotan-ii:v1","state":"current","stateChangedAt":"2026-11-15","title":"Combining MALDI mass spectrometry imaging and droplet-base surface sampling analysis for tissue distribution, metabolite profiling, and relative quantification of cyclic peptide melanotan II.","domain":"Literature metadata","dateInSource":"2021-03-01","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-32674774-melanotan-ii/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-32674774-melanotan-ii-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.md#pubmed-pmid-32674774-melanotan-ii-v1","contentSha256":"f4841c7cfe99d734dc817c7c788e26f85e65d968362e34775af849b7986cf819"},{"objectId":"story:pubmed-pmid-34464955-melanotan-ii:v1","state":"current","stateChangedAt":"2026-11-15","title":"Melanotan II User Experience: A Qualitative Study of Online Discussion Forums.","domain":"Literature metadata","dateInSource":"2022-02-15","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-34464955-melanotan-ii/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-34464955-melanotan-ii-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.md#pubmed-pmid-34464955-melanotan-ii-v1","contentSha256":"a388e1cafc7983d1dd399017dc25d73ee6fe6e7192d4fdac36959a8120891ca2"},{"objectId":"story:pubmed-pmid-35188390-melanotan-ii:v1","state":"current","stateChangedAt":"2026-11-15","title":"CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists.","domain":"Literature metadata","dateInSource":"2026-03-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-35188390-melanotan-ii/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-35188390-melanotan-ii-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.md#pubmed-pmid-35188390-melanotan-ii-v1","contentSha256":"9265473b1076673835e4d2086deb58f3860a8f18ace2310817a1ccb253350b4e"},{"objectId":"story:pubmed-pmid-38285527-melanotan-ii:v1","state":"current","stateChangedAt":"2026-11-15","title":"5-Hydroxypyrroloindoline Affords Tryptathionine and 2,2'-bis-Indole Peptide Staples: Application to Melanotan-II.","domain":"Literature metadata","dateInSource":"2024-04-08","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-38285527-melanotan-ii/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-38285527-melanotan-ii-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.md#pubmed-pmid-38285527-melanotan-ii-v1","contentSha256":"d8f3c297842f3d43412b9b2f2fe8ba1d97d8122a6f8207d44b03ddf3fd6b29c6"},{"objectId":"story:pubmed-pmid-7981427-melanotan-ii:v1","state":"current","stateChangedAt":"2026-11-15","title":"A comparison of HPLC and bioassay methods for plasma melanotan-II (MT-II) determination: application to a pharmacokinetic study in rats.","domain":"Literature metadata","dateInSource":"2019-10-23","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-7981427-melanotan-ii/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-7981427-melanotan-ii-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.md#pubmed-pmid-7981427-melanotan-ii-v1","contentSha256":"1d7a612373f3baee32c2fec1619e381838ea6fa94950f5c96a06b62b7bef0c59"},{"objectId":"story:pubmed-pmid-8637402-melanotan-ii:v1","state":"current","stateChangedAt":"2026-11-15","title":"Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study.","domain":"Literature metadata","dateInSource":"2019-07-01","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-8637402-melanotan-ii/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-8637402-melanotan-ii-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.md#pubmed-pmid-8637402-melanotan-ii-v1","contentSha256":"226b50f7f4eab3ab086d5c630630b494b3f10454d836a092f7d0a067235f6405"},{"objectId":"story:pubmed-pmid-9050812-melanotan-ii:v1","state":"current","stateChangedAt":"2026-11-15","title":"Systemic delivery of melanotan II through the ocular route in rabbits.","domain":"Literature metadata","dateInSource":"2006-04-13","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-9050812-melanotan-ii/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-9050812-melanotan-ii-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.md#pubmed-pmid-9050812-melanotan-ii-v1","contentSha256":"8a0aab90e7e6a33b1f912cf4aa5a4679d7c081048f33642975a47b52d25118bd"},{"objectId":"story:pubmed-pmid-9106033-melanotan-ii:v1","state":"current","stateChangedAt":"2026-11-15","title":"Determination of melanotan II in rabbit urine using solid-phase extraction sample preparation followed by reversed-phase high-performance liquid chromatography.","domain":"Literature metadata","dateInSource":"2019-08-31","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-9106033-melanotan-ii/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.json#pubmed-pmid-9106033-melanotan-ii-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/melanotan-ii.md#pubmed-pmid-9106033-melanotan-ii-v1","contentSha256":"9624e71cace99589256c76d71c64eeca26e81ff7c01748bfc49fb56ec1cc1946"}]}
